Literature DB >> 27296691

Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma.

Y C Chen1, Y F Liaw2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27296691     DOI： 10.1111/apt.13674

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  1 in total

1.  Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors' reply.

Authors:  P P Gounder; L R Bulkow; B J McMahon
Journal:  Aliment Pharmacol Ther       Date:  2016-09       Impact factor: 8.171
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.